Literature DB >> 17098952

Has the change to acellular pertussis vaccine improved or worsened pertussis control?

Scott A Halperin1, Gaston De Serres.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17098952      PMCID： PMC1626494          DOI： 10.1503/cmaj.060817

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine.

Authors:  G De Serres; R Shadmani; N Boulianne; B Duval; L Rochette; M Douville Fradet; S A Halperin
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

2.  Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

Authors:  David W Scheifele; Scott A Halperin
Journal:  Semin Pediatr Infect Dis       Date:  2003-07

Review 3.  Changing epidemiology and emerging risk groups for pertussis.

Authors:  Eleni Galanis; Arlene S King; Paul Varughese; Scott Alan Halperin
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

4.  Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population.

Authors:  A D Bentsi-Enchill; S A Halperin; J Scott; K MacIsaac; P Duclos
Journal:  Vaccine       Date:  1997-02       Impact factor: 3.641

5.  The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.

Authors:  Julie A Bettinger; Scott A Halperin; Gaston De Serres; David W Scheifele; Theresa Tam
Journal:  Pediatr Infect Dis J       Date:  2007-01       Impact factor: 2.129

6.  Effectiveness of a whole cell pertussis vaccine in child-care centers and schools.

Authors:  G De Serres; N Boulianne; B Duval; P Déry; A M Rodriguez; R Massé; S Halperin
Journal:  Pediatr Infect Dis J       Date:  1996-06       Impact factor: 2.129

7.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

8.  Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program.

Authors:  S A Halperin; R Bortolussi; D MacLean; N Chisholm
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

9.  Pertussis resurgence in Canada largely caused by a cohort effect.

Authors:  Benoît Ntezayabo; Gaston De Serres; Bernard Duval
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

10.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

Authors:  L Gustafsson; H O Hallander; P Olin; E Reizenstein; J Storsaeter
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245
View more
  2 in total

1.  Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age.

Authors:  Ronald Gold; Luis Barreto; Santiago Ferro; John Thippawong; Roland Guasparini; William Meekison; Margaret Russell; Elaine Mills; Dana Harrison; Pierre Lavigne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 2.  Pertussis. A reemerging and an underreported infectious disease.

Authors:  Muhammad A Syed; Noureen F Bana
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.